A001540 Stock Overview
Manufactures and sells pharmaceutical products. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 4/6 |
| Financial Health | 4/6 |
| Dividends | 2/6 |
My Notes
Capture your thoughts, links and company narrative
Ahn-Gook Pharmaceutical Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩6,590.00 |
| 52 Week High | ₩9,820.00 |
| 52 Week Low | ₩6,240.00 |
| Beta | 0.68 |
| 1 Month Change | -0.90% |
| 3 Month Change | -7.44% |
| 1 Year Change | -29.74% |
| 3 Year Change | -33.10% |
| 5 Year Change | -42.94% |
| Change since IPO | -38.65% |
Recent News & Updates
Statutory Earnings May Not Be The Best Way To Understand Ahn-Gook Pharmaceutical's (KOSDAQ:001540) True Position
Aug 26
Pinning Down Ahn-Gook Pharmaceutical Co., Ltd.'s (KOSDAQ:001540) P/E Is Difficult Right Now
Aug 13Recent updates
Statutory Earnings May Not Be The Best Way To Understand Ahn-Gook Pharmaceutical's (KOSDAQ:001540) True Position
Aug 26Pinning Down Ahn-Gook Pharmaceutical Co., Ltd.'s (KOSDAQ:001540) P/E Is Difficult Right Now
Aug 13Are Dividend Investors Making A Mistake With Ahn-Gook Pharmaceutical Co., Ltd. (KOSDAQ:001540)?
Apr 02Ahn-Gook Pharmaceutical (KOSDAQ:001540) Shareholders Booked A 29% Gain In The Last Year
Mar 07Is Ahn-Gook Pharmaceutical (KOSDAQ:001540) Using Too Much Debt?
Feb 14Do Insiders Own Lots Of Shares In Ahn-Gook Pharmaceutical Co., Ltd. (KOSDAQ:001540)?
Jan 19Dividend Investors: Don't Be Too Quick To Buy Ahn-Gook Pharmaceutical Co., Ltd. (KOSDAQ:001540) For Its Upcoming Dividend
Dec 24A Look At The Fair Value Of Ahn-Gook Pharmaceutical Co., Ltd. (KOSDAQ:001540)
Dec 10Key Things To Consider Before Buying Ahn-Gook Pharmaceutical Co., Ltd. (KOSDAQ:001540) For Its Dividend
Nov 18
Shareholder Returns
| A001540 | KR Pharmaceuticals | KR Market | |
|---|---|---|---|
| 7D | -2.5% | -2.3% | 0.3% |
| 1Y | -29.7% | 11.7% | -1.5% |
Return vs Industry: A001540 underperformed the KR Pharmaceuticals industry which returned 11.7% over the past year.
Return vs Market: A001540 underperformed the KR Market which returned -1.5% over the past year.
Price Volatility
| A001540 volatility | |
|---|---|
| A001540 Average Weekly Movement | 3.2% |
| Pharmaceuticals Industry Average Movement | 5.6% |
| Market Average Movement | 6.7% |
| 10% most volatile stocks in KR Market | 12.8% |
| 10% least volatile stocks in KR Market | 3.4% |
Stable Share Price: A001540 has not had significant price volatility in the past 3 months compared to the KR market.
Volatility Over Time: A001540's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1959 | 400 | June-Sun Auh | www.ahn-gook.com |
Ahn-Gook Pharmaceutical Co., Ltd. manufactures and sells pharmaceutical products. The company's pharmaceutical products include Cinatura and Revo Tension. The company was founded in 1959 and is headquartered in Seoul, South Korea.
Ahn-Gook Pharmaceutical Co., Ltd. Fundamentals Summary
| A001540 fundamental statistics | |
|---|---|
| Market cap | ₩75.35b |
| Earnings (TTM) | ₩14.28b |
| Revenue (TTM) | ₩264.64b |
5.2x
P/E Ratio0.3x
P/S RatioIs A001540 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A001540 income statement (TTM) | |
|---|---|
| Revenue | ₩264.64b |
| Cost of Revenue | ₩105.20b |
| Gross Profit | ₩159.44b |
| Other Expenses | ₩145.16b |
| Earnings | ₩14.28b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.26k |
| Gross Margin | 60.25% |
| Net Profit Margin | 5.40% |
| Debt/Equity Ratio | 46.7% |
How did A001540 perform over the long term?
See historical performance and comparisonDividends
3.3%
Current Dividend Yield18%
Payout RatioDoes A001540 pay a reliable dividends?
See A001540 dividend history and benchmarks| Ahn-Gook Pharmaceutical dividend dates | |
|---|---|
| Ex Dividend Date | Dec 27 2024 |
| Dividend Pay Date | Apr 18 2025 |
| Days until Ex dividend | 25 days |
| Days until Dividend pay date | 87 days |
Does A001540 pay a reliable dividends?
See A001540 dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/20 17:17 |
| End of Day Share Price | 2025/01/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Ahn-Gook Pharmaceutical Co., Ltd. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Min-young Lee | Korea Investment & Securities Co., Ltd. |